Want to join the conversation?
Chicago-based pharmaceutical company $ABBV reported 4Q15 profit of $1.51Bil, or $0.92 per share compared to net loss of $810MM or $0.51 per share, a year earlier. Total revenue for the quarter grew 17% to $6.4Bil. Total company revenue growth was driven by $554MM in global VIEKIRA sales and strong operational growth from Duodopa, Creon and Lupron.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.